Speech-Language Pathologists in Ephrata, PA Accepting Medicare

9 Speech-Language Pathologists found. Showing 1 - 9

Mrs. Sharon P. Bingaman, M.S. , CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 169 Martin Ave, Ephrata, PA 17522 Phone: 717-738-6634

Mrs. Patricia Joann Fuehrer, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 136e Lake St, Ephrata, PA 17522 Phone: 717-738-7979    Fax: 717-738-7970

Mrs. Sandra Lynne Miller Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4131e Oregon Pike, Ephrata, PA 17522 Phone: 717-859-5531

Mr. Rhonda Ulrich, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 136e Lake St, Ephrata, PA 17522 Phone: 717-738-7979    Fax: 717-738-7970

Mrs. Patricia Ann Benson, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 914 N Reading Rd, Ephrata, PA 17522 Phone: 717-335-3036    Fax: 717-336-5535

Bethany Rudy, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 333 Wheat Ridge Dr, Ephrata, PA 17522 Phone: 717-354-1858

Geordann Weik, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 169 Martin Ave, Ephrata, PA 17522 Phone: 717-733-0311

Carolyn Bell Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 333 Wheat Ridge Dr, Ephrata, PA 17522 Phone: 717-354-1858

Ms. Heather Noelle Martin, MS CCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 99 Bethany Rd, Ephrata, PA 17522 Phone: 610-743-3793

News Archive

Combining oral drug with personalized cell therapy can lead to complete remission in CLL patients

Combining the kinase inhibitor ibrutinib with an investigational personalized cellular therapy known as CTL119 can lead to complete remission in patients with high-risk chronic lymphocytic leukemia (CLL), according to new research from the Perelman School of Medicine at the University of Pennsylvania and Penn's Abramson Cancer Center

Adult day health programs help senior participants maintain their health and independence

A recent study by San Francisco's Institute on Aging documents that adult day health programs play a vital role in helping senior participants maintain their health and independence. Since the 1970s, adult day health care has been promoted as an alternative to nursing home care for seniors with chronic illness, disability, or dementia.

Natural products isolated from marine mollusks and sponges can reverse multidrug resistance in cancer cells

Many marine natural products show anticancer activity, but some can reverse multidrug resistance in cancer cells. A new investigation by Robert J. Capon of the University of Queensland correlates the products' structures with their activity.

FDA approves Stiefel's Sorilux Foam sNDA to treat for scalp psoriasis

Stiefel, a GSK company, today announced that the US Food and Drug Administration has approved a supplemental New Drug Application (sNDA) for Sorilux (calcipotriene) Foam, 0.005%. The sNDA expands the indication for Sorilux Foam to include the topical treatment of plaque psoriasis of the scalp in patients aged 18 years and older.

Read more Medical News

› Verified 5 days ago